The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Nivolumab plus ipilimumab (N+I) in patients (pts) with solid tumors with high tumor mutational burden (HTMB): Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) Study.
 
John K Chan
Honoraria - AstraZeneca; Eisai; Genmab/Seagen; GlaxoSmithKline/Tesaro; Merck; Myriad Genetics
Consulting or Advisory Role - Agenus; AstraZeneca; Eisai; Immunogen; Mersana; Myriad Genetics; Roche/Genentech; Seagen; Tesaro/GSK
Speakers' Bureau - AstraZeneca; Genmab/Seagen; GlaxoSmithKline/Tesaro; Immunogen; Myriad Genetics
Travel, Accommodations, Expenses - AstraZeneca; Genmab/Seagen; GlaxoSmithKline; Myriad Genetics
 
Michael Rothe
No Relationships to Disclose
 
Pam K. Mangat
No Relationships to Disclose
 
Elizabeth Garrett-Mayer
No Relationships to Disclose
 
Timothy Lewis Cannon
Honoraria - AstraZeneca; Bayer; Sirflex; Sirflex
Consulting or Advisory Role - Intermountain Healthcare
Other Relationship - Navican/ Intermountain Healthcare
 
Eugene R. Ahn
No Relationships to Disclose
 
Paul Swiecicki
Honoraria - CDR-Life; Elevar Therapeutics; Elevar Therapeutics; Geovax Labs; Prelude Therapeutics; Remix Therapeutics; Seagen
Research Funding - Ascentage Pharma Group (Inst)
 
Evthokia Hobbs
No Relationships to Disclose
 
Reza Nazemzadeh
Stock and Other Ownership Interests - Akero Therapeutics; Alector; Amgen; ESSA; Exelixis; Johnson & Johnson; Kura Oncology; Macrogenics
 
Maria C Bell
No Relationships to Disclose
 
Peter Joel Hosein
Honoraria - AngioDynamics
Research Funding - Eisai (Inst)
 
Funda Meric-Bernstam
Employment - MD Anderson Cancer Center
Honoraria - Dava Oncology
Consulting or Advisory Role - Abbvie; AstraZeneca; Black Diamond Therapeutics; Calibr; Daiichi Sankyo/Astra Zeneca; EcoR1 Capital; Eisai; Exelixis; GT Aperion; Incyte; Infinity Pharmaceuticals; Karyopharm Therapeutics; LegoChem Biosciences; Lengo Therapeutics; Menarini Group; OnCusp Therapeutics; Protai; Seagen; Tallac Therapeutics; Theratechnologies; Zentalis; Zymeworks
Research Funding - Abbvie (Inst); Aileron Therapeutics (Inst); AstraZeneca (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Calithera Biosciences (Inst); Curis (Inst); CytomX Therapeutics (Inst); Daiichi Sankyo (Inst); Debiopharm Group (Inst); eFFECTOR Therapeutics (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Guardant Health (Inst); Jazz Pharmaceuticals (Inst); Klus Pharma (Inst); Novartis (Inst); Pfizer (Inst); PUMA Biotechnology (Inst); Seagen (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst); Zymeworks (Inst)
Travel, Accommodations, Expenses - ARTIDIS; Cholangiocarcinoma Foundation; Dava Oncology; ESMO; European Organisation for Research and Treatment of Cancer (EORTC)
 
Dominique C. Hinshaw
No Relationships to Disclose
 
Abby Gregory
Employment - Biohaven Pharmaceuticals (I); Pfizer (I)
Stock and Other Ownership Interests - Biohaven Pharmaceuticals (I)
 
Gina N. Grantham
No Relationships to Disclose
 
Susan Halabi
Employment - ASCO
Consulting or Advisory Role - Aveo; Bristol-Myers Squibb; CG Oncology; J&J; Sanofi
Research Funding - Astellas Pharma (Inst)
 
Richard L. Schilsky
Leadership - Clarified Precision Medicine; Leap Therapeutics
Stock and Other Ownership Interests - EQRx; Leap Therapeutics
Honoraria - Toray Industries
Consulting or Advisory Role - AADi; Bryologyx; Cellworks; EQRx; Flatiron Health; Illumina; Scandion Oncology; Syapse; Zephyr AI
Research Funding - AstraZeneca (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Lilly (Inst); Merck (Inst); Pfizer (Inst); Seagen (Inst); Taiho Oncology (Inst)